Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-25-057685

Chief Business Officer acquired 22,714 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Doughty Christopher Grant · Chief Business Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2025-12-15 Grant or award : show line 1 in the form +14,714 54,194 D
2025-12-15 Grant or award : show line 2 in the form +8,000 62,194 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-15 Grant or award : show line 3 in the form Stock Option (Right to Buy) +58,855 58,855 D
Loading xslF345X05/wk-form4_1766008052.xml…